Importance:
Chronic periodontitis, a destructive inflammatory disorder of the supporting structures of the teeth, is prevalent in patients with diabetes. Limited evidence suggests that periodontal therapy may improve glycemic control.
Objective:
To determine if nonsurgical periodontal treatment reduces levels of glycated hemoglobin (HbA1c) in persons with type 2 diabetes and moderate to advanced chronic periodontitis.
Design, Setting, And Participants:
The Diabetes and Periodontal Therapy Trial (DPTT), a 6-month, single-masked, multicenter, randomized clinical trial. Participants had type 2 diabetes, were taking stable doses of medications, had HbA1c levels between 7% and less than 9%, and untreated chronic periodontitis. Five hundred fourteen participants were enrolled between November 2009 and March 2012 from diabetes and dental clinics and communities affiliated with 5 academic medical centers.
Interventions:
The treatment group (n = 257) received scaling and root planing plus chlorhexidine oral rinse at baseline and supportive periodontal therapy at 3 and 6 months. The control group (n = 257) received no treatment for 6 months.
Main Outcomes And Measures:
Difference in change in HbA1c level from baseline between groups at 6 months. Secondary outcomes included changes in probing pocket depths, clinical attachment loss, bleeding on probing, gingival index, fasting glucose level, and Homeostasis Model Assessment (HOMA2) score.
Results:
Enrollment was stopped early because of futility. At 6 months, mean HbA1c levels in the periodontal therapy group increased 0.17% (SD, 1.0), compared with 0.11% (SD, 1.0) in the control group, with no significant difference between groups based on a linear regression model adjusting for clinical site (mean difference, -0.05% [95% CI, -0.23% to 0.12%]; P = .55). Periodontal measures improved in the treatment group compared with the control group at 6 months, with adjusted between-group differences of 0.28 mm (95% CI, 0.18 to 0.37) for probing depth, 0.25 mm (95% CI, 0.14 to 0.36) for clinical attachment loss, 13.1% (95% CI, 8.1% to 18.1%) for bleeding on probing, and 0.27 (95% CI, 0.17 to 0.37) for gingival index (P < .001 for all).
Conclusions And Relevance:
Nonsurgical periodontal therapy did not improve glycemic control in patients with type 2 diabetes and moderate to advanced chronic periodontitis. These findings do not support the use of nonsurgical periodontal treatment in patients with diabetes for the purpose of lowering levels of HbA1c.
Trial Registration:
clinicaltrials.gov Identifier: NCT00997178.
Citing Articles
Pathogenic Mechanisms That May Link Periodontal Disease and Type 2 Diabetes Mellitus-The Role of Oxidative Stress.
Mirnic J, Djuric M, Brkic S, Gusic I, Stojilkovic M, Tadic A
Int J Mol Sci. 2024; 25(18).
PMID: 39337292
PMC: 11432179.
DOI: 10.3390/ijms25189806.
A Roadmap for the Rational Use of Biomarkers in Oral Disease Screening.
Cirillo N
Biomolecules. 2024; 14(7).
PMID: 39062501
PMC: 11274832.
DOI: 10.3390/biom14070787.
Association between dental visit behavior and mortality: a nationwide longitudinal cohort study from NHANES.
Xu K, Ma S, Gu J, Liu Q, He Z, Li Y
Clin Oral Investig. 2023; 28(1):37.
PMID: 38148418
DOI: 10.1007/s00784-023-05471-8.
Systematic review and meta-analysis of randomized controlled trials evaluating the efficacy of non-surgical periodontal treatment in patients with concurrent systemic conditions.
Joseph P, Prabhakar P, Holtfreter B, Pink C, Suvan J, Kocher T
Clin Oral Investig. 2023; 28(1):21.
PMID: 38147183
PMC: 10751251.
DOI: 10.1007/s00784-023-05392-6.
Collagenase-Responsive Hydrogel Loaded with GSK2606414 Nanoparticles for Periodontitis Treatment through Inhibiting Inflammation-Induced Expression of PERK of Periodontal Ligament Stem Cells.
Zhou Y, Liu J, Xue P, Zhang J
Pharmaceutics. 2023; 15(10).
PMID: 37896262
PMC: 10609791.
DOI: 10.3390/pharmaceutics15102503.
Periodontal treatment and subsequent clinical outcomes and medical care costs: A retrospective cohort study.
Michalowicz B, Anderson J, Kottke T, Dehmer S, Worley D, Kane S
PLoS One. 2023; 18(8):e0290028.
PMID: 37578943
PMC: 10424874.
DOI: 10.1371/journal.pone.0290028.
Periodontitis treatment (surgical and nonsurgical) effects on glycemic control: A review and meta-analysis.
Elnour M, Mirghani H
Ann Afr Med. 2023; 22(2):131-135.
PMID: 37026192
PMC: 10262851.
DOI: 10.4103/aam.aam_53_22.
Regulatory mechanisms of GCN5 in osteogenic differentiation of MSCs in periodontitis.
Lu W, Zhang L, Ji K, Ding L, Wu G
Clin Exp Dent Res. 2023; 9(3):464-471.
PMID: 37021521
PMC: 10280614.
DOI: 10.1002/cre2.695.
Preoperative HbA1c and Blood Glucose Measurements in Diabetes Mellitus before Oral Surgery and Implantology Treatments.
Vegh D, Bencze B, Banyai D, Vegh A, Rozsa N, Nagy Dobo C
Int J Environ Res Public Health. 2023; 20(6).
PMID: 36981651
PMC: 10048655.
DOI: 10.3390/ijerph20064745.
Effect of periodontal therapy on insulin resistance in adults with dysglycemia and periodontitis: a systematic review and meta-analysis.
Greggianin B, Marques A, Amato A, de Lima C
Clin Oral Investig. 2023; 27(4):1329-1342.
PMID: 36790626
DOI: 10.1007/s00784-023-04879-6.
Periodontal diseases assessed by average bone resorption are associated with microvascular complications in patients with type 2 diabetes.
Sugi N, Eguchi E, Tsuboi A, Hatanaka K, Takashiba S, Kira Y
Diabetol Int. 2023; 14(1):32-39.
PMID: 36636165
PMC: 9829934.
DOI: 10.1007/s13340-022-00591-0.
Association between Periodontitis and Diabetes Mellitus in the General Population.
Mehriz B, Atteya M, Skipina T, Mostafa M, Soliman E
J Diabetes Metab Disord. 2022; 21(2):1249-1254.
PMID: 36404812
PMC: 9672178.
DOI: 10.1007/s40200-022-01010-6.
Effects of Nonsurgical Periodontal Therapy on Salivary 8-Hydroxy-Deoxyguanosine Levels and Glycemic Control in Diabetes Mellitus Type 2 Patients.
Mirnic J, Djuric M, Gusic I, Veljovic T, Cakic S, Katanic J
Biomedicines. 2022; 10(9).
PMID: 36140370
PMC: 9496046.
DOI: 10.3390/biomedicines10092269.
Effects of One-Stage Full-Mouth Scaling and Root Planing with Azithromycin on Diabetes and Periodontal Disease: A Randomized Controlled Trial.
Komatsu S, Oshikiri S, Nagano T, Yashima A, Matsushima Y, Shirakawa S
Antibiotics (Basel). 2022; 11(9).
PMID: 36140045
PMC: 9495786.
DOI: 10.3390/antibiotics11091266.
Policies Supporting Oral Health in Ageing Populations Are Needed Worldwide.
Chavez E, Kossioni A, Fukai K
Int Dent J. 2022; 72(4S):S27-S38.
PMID: 36031323
PMC: 9437798.
DOI: 10.1016/j.identj.2022.06.014.
Mendelian randomization supports the causal role of fasting glucose on periodontitis.
Wang Y, Chu T, Gong Y, Li S, Wu L, Jin L
Front Endocrinol (Lausanne). 2022; 13:860274.
PMID: 35992145
PMC: 9388749.
DOI: 10.3389/fendo.2022.860274.
Bidirectional Relationship Between Osteoarthritis and Periodontitis: A Population-Based Cohort Study Over a 15-year Follow-Up.
Ma K, Lai J, Thota E, Yip H, Chin N, Cheng-Chung Wei J
Front Immunol. 2022; 13:909783.
PMID: 35958545
PMC: 9358960.
DOI: 10.3389/fimmu.2022.909783.
Treatment of periodontitis for glycaemic control in people with diabetes mellitus.
Simpson T, Clarkson J, Worthington H, MacDonald L, Weldon J, Needleman I
Cochrane Database Syst Rev. 2022; 4:CD004714.
PMID: 35420698
PMC: 9009294.
DOI: 10.1002/14651858.CD004714.pub4.
Age-dependent oral manifestations of neurofibromatosis type 1: a case-control study.
Thota E, Veeravalli J, Manchala S, Lakkepuram B, Kodapaneni J, Chen Y
Orphanet J Rare Dis. 2022; 17(1):93.
PMID: 35236379
PMC: 8889631.
DOI: 10.1186/s13023-022-02223-x.
Impact of Liability to Periodontitis on Glycemic Control and Type II Diabetes Risk: A Mendelian Randomization Study.
Shah P, Schooling C, Borrell L
Front Genet. 2021; 12:767577.
PMID: 34899852
PMC: 8660586.
DOI: 10.3389/fgene.2021.767577.